Current through Register 2024 Notice Reg. No. 38, September 20, 2024
(a) CCS applicants shall be eligible for
participation in the CCS program for diagnostic services to determine the
presence of a hearing loss when the applicant:
(1) Fails two pure tone audiometric hearing
screening tests performed at least six weeks apart at levels not to exceed 25
decibels and at the minimum number of frequencies of 1000, 2000 and 4000 Hertz;
or
(2) Fails to have normal
auditory brain stem evoked response; or
(3) Fails otoacoustic emission or behavioral
responses to auditory stimuli as determined by two tests performed at least six
weeks apart; or
(4) Fails to pass
hearing screening provided through the Newborn and Infant Hearing Screening,
Tracking and Intervention Program, pursuant to Health and Safety Code Sections
123975 and 124115 through 124120.5; or
(5) Exhibits symptoms that may indicate a
hearing loss such as poor speech for age or delay in age-appropriate behavioral
milestones; or
(6) Has
documentation of one of the risk factors associated with a sensorineural
hearing or conductive hearing loss such as:
(A) A family history of congenital or
childhood onset of hearing impairment.
(B) Congenital infection known or suspected
to be associated with hearing loss.
(C) Craniofacial anomalies.
(D) Hyperbilirubinemia at a level exceeding
the indication for an exchange transfusion.
(E) Ototoxic medications used for more than
five days.
(F) Bacterial
meningitis.
(G) Severe depression
at birth, defined as:
1. Apgar score of three
or less;
2. Failure to initiate
spontaneous respirations by ten minutes of age; or
3. Hypotonia persisting to two hours of
age.
(H) Prolonged
mechanical ventilation for a duration of at least five days.
(I) Findings of a syndrome known to be
associated with hearing loss.
(b) If either of the tests referenced in
(a)(1) and (3) above are performed by an audiologist or otolaryngologist, only
one exam shall be required for eligibility for diagnostic testing.
(c) CCS applicants shall be eligible for
participating in the CCS program for treatment services when there is a hearing
loss present as defined by the following criteria:
(1) In children over five years of age, a
pure tone audiometric loss of 30 decibels or greater at two or more frequencies
in the same ear tested at 500, 1000, 2000, 3000, 4000, 6000, 8000 Hertz or a
loss of 40 decibels or greater at any one frequency between and including 500
through 8000 Hertz;
(2) In children
from three to five years of age, a pure tone audiometric loss of 30 decibels or
greater at any frequency tested at 500, 1000, 2000, 3000, 4000, 6000, 8000
Hertz; or
(3) In children unable to
complete a pure tone audiometric test and whose auditory brain stem evoked
response, or otoacoustic emission, or behavioral responses to auditory stimuli
indicate hearing loss of 30 decibels or greater.
(d) CCS applicants shall be eligible for
participation in the CCS program for treatment services when there is:
(1) Perforation of the tympanic membrane that
requires tympanoplasty; or
(2)
Mastoiditis; or
(3)
Cholesteatoma.
(e)
Congenital anomalies of the ear and mastoid process that meet the criteria of
section 41518.8.
1. New
section filed 12-31-90; operative 1-30-91 (Register 91, No. 8).
2.
Change without regulatory effect renumbering former section 41518 to new
section 41452 and renumbering former
section 41839 to section 41518, including
amendment of subsections (a)(4) and (e) and NOTE, filed 1-28-2009 pursuant to
section 100, title 1, California Code of
Regulations (Register 2009, No. 5).
Note: Authority cited: Sections
20
and
100275,
Health and Safety Code. Reference: Sections
123830,
123835,
and
123975,
Health and Safety Code.
